Skip to main content
Clinical Trials/CTRI/2022/08/044843
CTRI/2022/08/044843
Completed
Phase 2

Randomized controlled trial to evaluate efficacy and safety of plant protein source in comparison with whey protein concentrate (80%) in improving muscle mass, strength and stamina in male subjects with active lifestyle. - Nil

Medizen Labs Pvt Ltd0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Medizen Labs Pvt Ltd
Enrollment
60
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 21, 2022
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Medizen Labs Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\. Male subjects aged between 18\-40 years having BMI less than 35 kg/m2
  • 2\. Resting blood pressure averaging less than 140/90 mmHg.
  • 3\. Not on any medication for cardiovascular and metabolic disorders.
  • 4\. Willing to undergo full body resistance training three times per week (3 exercises, 3 sets of 8\-12 repetitions per set).
  • 5\. Willing to provide consent.
  • 6\.Willing for follow up.

Exclusion Criteria

  • 1\. Subjects with any acute illness requiring immediate medical care.
  • 2\.Subjects with any chronic medical condition.
  • 3\. Subjects with sedentary lifestyle not able or not advised to undergo the resistance training as per protocol.
  • 4\. Any clinically relevant macro or micro\-nutrient deficiency as per investigator discretion.
  • 5\. Any other condition which proves subject unfit for the study participation.
  • 6\. Any known cardiovascular or metabolic disease.

Outcomes

Primary Outcomes

Not specified

Similar Trials